Page last updated: 2024-11-04

sarpogrelate and Kidney Failure, Chronic

sarpogrelate has been researched along with Kidney Failure, Chronic in 1 studies

sarpogrelate: structure given in first source

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hidaka, S1
Kobayashi, S1
Iwagami, M1
Isshiki, R1
Tsutsumi, D1
Mochida, Y1
Ishioka, K1
Oka, M1
Maesato, K1
Moriya, H1
Ohtake, T1

Trials

1 trial available for sarpogrelate and Kidney Failure, Chronic

ArticleYear
Sarpogrelate hydrochloride, a selective 5-HT(2A) receptor antagonist, improves skin perfusion pressure of the lower extremities in hemodialysis patients with peripheral arterial disease.
    Renal failure, 2013, Volume: 35, Issue:1

    Topics: Aged; Blood Pressure; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Lower Extremity; M

2013